Thu. 22 Feb 2024, 4:04pm ET
Benzinga
Earnings, Earnings Beats, News
Biomarin Pharmaceutical (NASDAQ:BMRN) reported quarterly earnings of $0.49 per share which beat the analyst consensus estimate of $0.23 by 113.04 percent. The company reported quarterly sales of $646.20 million which beat the analyst consensus estimate of $636.88 million by 1.46 percent. This is a 20.21 percent increase over sales of $537.54 million the same period last year.